Tamoxifen is a potent inhibitor of specific oestrogen-induced yolk protein synthesis by chicken liver. The 
Non-steroidal anti-oestrogens can be classified as compounds that inhibit the binding of oestradiol to the oestrogen receptor and, possibly as a result, prevent the full expression of oestrogenic responses in target tissues. As yet no precise molecular mechanism has been described for anti-oestrogen action although several hypotheses have been suggested. Anti-oestrogens have been observed to inhibit cytoplasmic oestrogen receptor replenishment (Clark et al., 1974) , to interfere with processing of nuclear oestrogen receptor , and to produce some qualitative or quantitative defects in receptor activation and translocation Hayes et al., 1981; . Overall, the structurally specific anti-oestrogen-oestrogenreceptor complex appears to have a lower intrinsic Vol. 206 activity than the oestradiol-oestrogen-receptor complex, particularly for stimulating proliferative processes (Jordan et al., 1977a) .
Generation of a convincing general theory for the mechanism of anti-oestrogen action is frustrated by the species-specific effects of these compounds. The so-called anti-oestrogens exhibit full oestrogenic properties in short term tests in the mouse uterus (Terenius, 1971) , some oestrogenic responses (e.g. progesterone receptor synthesis; Jordan & Prestwich, 1978) and anti-oestrogenic responses (e.g. inhibition of mitosis; Jordan & Dix, 1979) in the rat uterus, and apparently universal anti-oestrogenic responses in the chick oviduct (Sutherland et al., 1977; Sutherland, 1981) .
Tamoxifen { (Z)-2-[p-(1,2-diphenylbut-1 -enyl)-phenoxyl-NN-dimethylethylamine 1, an anti-oestrogen used in the treatment of breast cancer (Patterson, 1981) , has several metabolites, monohydroxytamoxifen [(Z)-2-p-[1-(4-hydroxyphenyl)-2-phenyl-0306-3283/82/080387-08$01.50/1 (© 1982 The Biochemical Society but -1 -enylIphenoxy I -NN -dimethylethylaminel (Jordan et al., 1977b) and desmethyltamoxifen (Adam et al., 1979) that are anti-oestrogens in their own right. The metabolites may play an important role in the mechanism of action of tamoxifen because the administration of [ 3Hltamoxi-fen results in the localization of monohydroxy-[3Hltamoxifen in target cell nuclei and derivatives of tamoxifen that cannot undergo metabolic conversion to monohydroxytamoxifen have attenuated agonistic and antagonistic actions in the rat (Allen et al., 1980) . Tamoxifen, as well as nafoxidine and CI-628, are extraordinarily potent inhibitors of specific oestrogen-induced egg yolk protein synthesis in the chick liver (Gschwendt, 1975; Lazier & Alford, 1977; Capony & Williams, 1980) . However, earlier studies have shown that neither nafoxidine nor CI-628 competes to a significant degree with oestradiol binding to the liver nuclear oestrogen receptor, the presumed effector of oestrogen action (Gschwendt, 1975; Lazier & Alford, 1977) . We now find that tamoxifen, and particularly its monohydroxylated derivative, exhibit high affinity binding for this receptor.
Materials and methods Animals and injections
White leghorn cockerels of about lOOg body weight were used for all experiments. Oestradiol-17/3 and/or anti-oestrogen was dissolved in propylene glycol/ethanol (1:1, v/v) at the concentrations indicated in the text. Injections (0.2ml/lOOg body weight) were given intramuscularly.
Preparations of liverfractions Nuclei were purified from liver by centrifugation in glycerol-containing buffers using methods based on those described by Snow et al. (1978) . Briefly, minced liver was homogenized at 0°C in 10vol. of buffer containing 10mM-Tris/HCl (pH 7.5 at 250C)/ 10mM-NaCl/1.5 mM-MgCl2/50% (v/v) glycerol.
After centrifugation at 6000g for 15 min the crude nuclear pellet was washed twice with the homogenization buffer supplemented with detergents (0.05% Triton X-100 and 0.1% NP-40). The resulting pellet was washed twice in TGM buffer at 250C)/1 mM-MgCl2/ 25% (v/v) glycerol] and was suspended in TGM buffer at a concentration of about 1.5 mg of DNA/ml. For preparation of salt extracts, the nuclei were sedimented from suspension, and a volume of buffer B [0.5M-KCl/1.5mM-EDTA/lOmM-Tes (pH 7.4)/10mM-monothioglyceroll equal to the original suspension volume was added, giving a final KCI concentration of 0.4M. After vigorous vortexing, the salt extract was frozen, thawed and centrifuged at 3700Og for 20min. The chromatin fraction was prepared from the purified nuclei by washing three times in 10mM-Tris/HCl, pH 7.4, containing lOmM-MgCl2 and 10mM-monothioglycerol, swelling for 18 h in the same solution, followed by sedimentation at 100OOg for 10min and one additional wash and final suspension in TGM buffer.
Assay of PHloestradiol binding activity
The oestrogen receptor content of intact nuclei and of chromatin was measured by exchange at 300C (Snow et al., 1978 Binding activity of the nuclear salt extracts was determined by a modification of the charcoal adsorption technique reported previously (Lazier, 1978) . The extracts were usually stripped of endogenous steroid by preincubation at 370C for 15min with an equal volume of 0.5% charcoal/0.05% Dextran T70 in buffer B. After removal of the charcoal by centrifugation the extracts were incubated in a total volume of 0.3ml at 300C for 30min with [3Hloestradiol (8nM) in the absence or presence of a 100-fold excess of unlabelled diethylstilboestrol, cooled and charcoal-treated (as above) for 30 min at 0°C. Samples of the supernatant (0.4 ml) were counted for radioactivity in Aquasol II (New England Nuclear) at an efficiency of about 45%.
Anti-oestrogens
Because of the photosensitivity of monohydroxytamoxifen, solutions in ethanol were freshly prepared before each experiment. The anti-oestrogens were supplied by ICI, Macclesfield, Cheshire, U.K.
Results and discussion
Binding of tamoxifen and its derivatives to the liver oestrogen receptor in vitro Fixed concentrations of tamoxifen and monohydroxytamoxifen were incubated with nuclear salt extract and increasing concentrations of [3Hloestra-diol. The binding data were analysed by the classical Lineweaver-Burk method. 30-fold difference in the relative affinities of the two anti-oestrogens for the receptor. The KD for oestradiol is 0.73 + 0.21nM (S.D., for four preparations). Thus the affinity of monohydroxytamoxifen for the oestrogen receptor is several-fold greater than that of oestradiol itself.
Competition of the anti-oestrogens for the oestrogen receptor was also assessed in assays in which a fixed, saturating, concentration of [ 3Hloestradiol was incubated with increasing concentrations of unlabelled anti-oestrogen. In addition, we compared the competitive potential of the anti-oestrogens for receptor in intact purified nuclei and in salt extracts of the nuclei. This was of interest because studies on regulation of the nuclear oestrogen receptor had been carried out in both types of preparation (Snow et al., 1978; Lazier& Haggarty, 1979) . gives a relative binding affinity for tamoxifen of 9 and for monohydroxytamoxifen of 440. The relative effectiveness of the two anti-oestrogens derived by this method is similar to that found by comparison of the specific K, values determined on incubation for 30min at the same temperature (300C). The relative binding affinities of the anti-oestrogens were also determined upon incubation at 0°C for 18h (Table 1) . Unlike the case for certain other oestrogen analogues (Bouton & Raynaud, 1978) , no distinct temperature-dependent differences were found.
In intact nuclei, much higher concentrations of the anti-oestrogens are required to give 50% inhibition of [3Hloestradiol binding than are found for salt extracts (Fig. 2, Table 1 ). The relative effectiveness of monohydroxytamoxifen compared with tamoxifen is still observed, but the potency of both compounds is reduced 4-10-fold. An even more pronounced difference in inhibitory capacity is found when desmethyltamoxifen is tested in the two different receptor preparations. A possible explanation of this phenomenon is that the antioestrogens, but not oestradiol, incur substantial interactions with elements on the surface or on the interior of the nuclei. This results in lowering of the free inhibitor concentration available for competition with the specific oestradiol binding sites. Monobydroxytamoxifen shows less apparent affinity for oestrogen receptor in chromatin preparations than in nuclear salt extracts (Fig. 2c) . Thus at least some of the non-receptor anti-oestrogen binding is probably intranuclear, associated with chromatin. Distinctive high-affinity anti-oestrogen binding sites which do not bind oestradiol have recently been found in cytosol from chick liver and a variety of other target organs (Sutherland et al., 1980) , but nuclear binding sites have not been characterized. Exchange characteristics ofthe anti-oestrogens Considering the extremely high affinity of monohydroxytamoxifen for the salt-soluble nuclear oestrogen receptor, it was imperative to demonstrate that the conditions of an exchange assay used to assess nuclear oestrogen receptor concentration after treatment in vivo with anti-oestrogens actually were sufficient to permit dissociation of the ligand and subsequent binding of [3Hloestradiol. Furthermore, the apparent very high non-receptor binding of the anti-oestrogen in the isolated nuclei suggests that a reservoir of such ligand may be present in nuclei of anti-oestrogen-treated animals. Such ligand could dissociate during an exchange assay with 13Hi-oestradiol, and could inhibit binding of the labelled ligand to receptor sites and give a false impression of diminished receptor concentration. Earlier studies on the effect of anti-oestrogen treatment in chick liver or oviduct did not demonstrate that the exchange assay was thus adequate (Lazier & Alford, 1977; Binart et al., 1979; Lazier et al., 1981; Lebeau etal., 1981) .
In order to investigate exchange conditions, charcoal-treated salt extracts from liver nuclei of oestrogen-treated chickens were incubated with sufficient unlabelled anti-oestrogen or oestradiol to saturate the oestrogen receptor. The samples were treated with varying concentrations of charcoal suspension at different temperatures in order to remove unbound and possibly some, or all, of the bound ligand. of the appropriate controls. Table 2 shows that the conventional charcoal treatment (0.5% charcoal for 15 min at 0°C) (Sutherland & Baulieu, 1976; Lazier & Haggarty, 1979) permits quantitative detection of oestrogen receptor sites previously bound with oestradiol, tamoxifen or desmethyltamoxifen. However, sites previously bound with monohydroxytamoxifen are not detectable, possibly due to ineffective removal of all the non-receptor-bound ligand and as well to a very low dissociation rate for monohydroxytamoxifen from the oestrogen receptor. Increasing the charcoal concentration to 1.7% and the temperature of the charcoal to 370C permits assay of the majority of sites previously bound to monohydroxytamoxifen (Table 3 , A and B). The recovery is 60-70%, and is not improved by further increases in charcoal concentration, incubation temperature or time. Limited preincubation at 370C has a stimulating effect on subsequent [3HJoestradiol binding (Table 3, B) ; however, prolonged preincubation at 370C in the presence of high charcoal concentrations has a deleterious effect on the receptor. Other methods of promoting the exchange of tightly bound ligands such as the use of chaotropic agents (Sica et al., 1981) , were not found to be useful in this system.
The effect of anti-oestrogens in vivo on nuclear oestrogen receptor Earlier reports showed that nafoxidine, CI-628 or tamoxifen treatment of chicks resulted in an increase in the concentration of nuclear oestrogen Vol. 206 receptor which was quantitatively considerably less than, and temporally delayed, compared with that evoked by a similar dose of oestradiol (Gschwendt, 1975; Lazier & Alford, 1977; Lazier et al., 1981) . In the case of tamoxifen, it is clear that this compound has a sufficient rate of dissociation from the oestradiol receptor to permit assay under the usual exchange conditions. However, if tamoxifen is metabolized to the monohydroxylated form in vivo and the latter compound is actually that which is bound to the oestrogen receptor, then the usual assay conditions would not be-sufficient for quantitative assay. We now find that a relatively brief (4 h) exposure to tamoxifen or to monohydroxytamoxifen does give rise to a 4-6-fold increase in the nuclear oestrogen receptor concentration, as assayed in salt extracts by the modified charcoal treatment procedure (Table 4 ). No such increase was found by using the nuclear exchange assay. The experiments in vitro suggest that the exchange assays with intact nuclei are not valid reflections of the actual nuclear receptor concentrations because of high non-receptor binding of anti-oestrogen. Furthermore, it is unlikely that monohydroxytamoxifen bound to the receptor would dissociate under the conditions used. The measurements of receptor concentration made by the modified charcoal treatment technique with the salt extracts more likely give a truer picture of actual receptor levels. These figures are still limited by the 60-70% efficiency of the exchange reaction for monohydroxytamoxifen. Thus, the values given for nuclear receptor concentration in monohydroxytamoxifen-treated chicks and in the tamoxi- fen-treated chicks could be 30-40% low depending on the degree of metabolic hydroxylation.
The time course of the anti-oestrogen-induced increase in the nuclear oestrogen receptor concentration is shown in Fig. 3 . Unlike in earlier experiments where higher doses and conventional exchange techniques were used (Lazier et al., 1981) . we now find that tamoxifen injection produces a relatively rapid and sustained effect. Similar kinetics are found for monohydroxytamoxifen, while oestradiol injection results in a peak in nuclear receptor concentration at 4 h followed by gradual decline. given with oestradiol in vivo on the apparent concentration ofnuclear oestrogen receptor Tamoxifen (open symbols) or monohydroxytamoxifen (filled symbols) were given simultaneously with oestradiol (3 mg/kg) at the molar dose ratio indicated on the abscissa. After 4h, liver nuclei and nuclear salt extracts were prepared. [3HlOestradiol binding activity in intact nuclei was assayed by exchange at 30°C and the salt extracts were pretreated with 1.7% charcoal suspension for 15 min at 37°C prior to assay at 300C. 0,0, Salt extracts; A, A, intact nuclei. Results given are the means + S.D.
for duplicate determinations of preparations from each of three animals.
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These results most likely reflect differential clearance rates for oestradiol and anti-oestrogens in the chicken (Binart et al., 1979) . Fig. 4 shows the effect of different doses of the two anti-oestrogens given with oestradiol for 4h in vivo on the accumulation of nuclear oestrogen receptor. Both the nuclear exchange and the modified salt extract assays were used. Tamoxifen and monohydroxytamoxifen produce a similar degree of apparent inhibition. This is especially pronounced when binding is assessed by the assay with intact nuclei. Although the results may be artifactual in terms of true inhibition of nuclear receptor accumulation, they suggest that the metabolic transformation of tamoxifen to the higher affinity ligand is taking place.
For a mixed dose of anti-oestrogen and oestradiol the amounts of nuclear receptor-specific binding of anti-oestrogen and oestradiol would be proportional to their relative affinities for the receptor and to their intrahepatic concentrations. Thus, for a molar dose ratio of 1.5:1 (anti-oestrogen: oestrogen) it is possible that the majority of the intranuclear oestrogen receptor sites would be bound to monohydroxytamoxifen. If, as pointed out earlier, some 30-40% of these sites are not detectable in the salt extract assay, then it is obvious that there is little true inhibition of accumulation of nuclear receptor. Furthermore, the estimate that monohydroxytamoxifen constitutes the majority of nuclear-bound ligand at a molar dose ratio of 1.5:1 is consistent with observations on the striking anti-oestrogenic capacity of tamoxifen. Under these conditions, over 70% inhibition of oestradiol-induced synthesis of the apoprotein B of very low density lipoprotein is found (Capony & Williams, 1980) . Very high affinity binding of monohydroxytamoxifen relative to tamoxifen has been reported for the oestrogen receptor from chick oviduct (Binart et al., 1979) and from rat and calf uterine tissues (Jordan et al., 1977b; Borgna & Rochefort, 1980; Rochefort et al., 1979) . There is some controversy as to whether or not metabolism is an obligatory step in the anti-oestrogenic activity of tamoxifen. According to Binart et al. (1979) little monohydroxytamoxifen is found in chick oviduct after tamoxifen injection and no conversion occurs in the tissue in vitro, suggesting that hydroxylation is not a prerequisite. On the other hand, report that both oviduct and liver readily hydroxylate tamoxifen and conclude that hydroxylation is likely to be an important feature in its action. Derivatives of tamoxifen which cannot undergo hydroxylation have been tested for uterotropic effects in the rat (Allen et al., 1980) . Although greatly attenuated, the derivatives retain some antagonistic and agonistic potential, demonstrating that, in this case, metabolic hydroxylation is an advantage, but not an absolute prerequisite, for anti-oestrogen action. A similar situation appears to hold in the case of the human breast tumour cell line, MCF-7 .
The very high affinity of monohydroxytamoxifen for the liver nuclear oestrogen receptor makes it an interesting and potentially useful compound for further study. Our results underline the necessity for thorough investigation of exchange assay conditions for anti-oestrogens and their metabolites in order to assess their effects on nuclear receptor accumulation. With one possible exception (Hayes et al., 1981) , it appears that reports of defective oestrogen receptor translocation by anti-oestrogens could be reinterpreted in terms of high affinity binding of the administered compound or a metabolite interfering with the nuclear exchange assay (Gschwendt, 1975; Lazier & Alford, 1977; Lazier et al., 1981; Binart et al., 1979; Lebeau etal., 1981) .
